Kenta Yokoi Selected Research

Kenta Yokoi Research Topics

11	Neoplasms (Cancer) 09/2023 - 02/2013
2	Hepatocellular Carcinoma (Hepatoma) 02/2018 - 04/2015
2	Necrosis 01/2018 - 01/2018
1	Poisoning 09/2023
1	Iron Overload 09/2023
1	Carcinoma (Carcinomatosis) 02/2023
1	Hemorrhage 01/2022
1	Cholangiocarcinoma 02/2018
1	Colorectal Neoplasms (Colorectal Cancer) 02/2013
1	Neoplasm Metastasis (Metastasis) 04/2012
1	Rectal Neoplasms (Rectal Cancer) 04/2012

7	Peptides (Polypeptides)IBA 01/2022 - 01/2018
6	IridiumIBA 02/2023 - 01/2018
3	LigandsIBA 09/2023 - 01/2018
2	TriterpenesIBA 01/2022 - 11/2021
2	celastrolIBA 01/2022 - 11/2021
1	CationsIBA 09/2023
1	MetalsIBA 09/2023
1	IronIBA 09/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2023
1	Oxygen (Dioxygen)IBA 02/2023
1	Photosensitizing Agents (Photosensitizers)IBA 02/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2023
1	Singlet OxygenIBA 02/2023
1	CalciumIBA 01/2022
1	triptyceneIBA 01/2022
1	2-phenylpyridineIBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2019
1	Lysine (L-Lysine)FDA Link 10/2019
1	Sorafenib (BAY 43-9006)FDA Link 02/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Death Domain ReceptorsIBA 01/2018
1	Bevacizumab (Avastin)FDA Link 02/2013
1	AntibodiesIBA 02/2013
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2012

3	Drug Therapy (Chemotherapy) 09/2023 - 04/2012
3	Therapeutics 02/2023 - 01/2018
1	Chelation Therapy (Therapy, Chelation) 09/2023
1	Photochemotherapy (Photodynamic Therapy) 02/2023
1	Splenectomy 01/2022
1	Hepatectomy 04/2015
1	Withholding Treatment 02/2013